This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Karin B. Nelson, MD

JAMA. 1996;276(22):1843-1844.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Very low-birth-weight infants, those born weighing less than 1500 g, are at high risk for neurologic disability: 1 in 20 survivors has disabling cerebral palsy,¹ and many have other neurologic or sensory difficulties. Mortality among these tiny infants, almost all of whom are very premature, has decreased strikingly, but the rate of births in that weight group has not lessened. The increasing contribution of this group to the burden of disability is a source of concern.² A measure that might reduce neurologic morbidity among surviving very low-birth-weight infants would be desirable indeed.

See also p 1805.

Recent studies^3,4 have found that prenatal exposure to magnesium sulfate in very low-birth-weight infants was associated with reduction in cerebral palsy. Dr Schendel and colleagues⁵ have now confirmed and extended these findings. The contribution of their work is 3-fold: First, they provide evidence that the inverse association of magnesium sulfate . . . [Full Text PDF of this Article]

Author Affiliations
From the Neuroepidemiology Branch, National Institutes of Health, Bethesda, Md.

Footnotes
Reprints: Karin B. Nelson, MD, Neuroepidemiology Branch, National Institutes of Health, 7550 Wisconsin Ave, Room 714 FB, Bethesda, MD 20892-9130 (e-mail: knelson@helix.nih.gov).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?